Abstract
The natural history of AE is that of a slowly progressive disease, often presenting in mild form. Untreated, AE is potentially fatal and one third of these reported cases have led to patient death.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Dillaha CJ, Lorincz AL, Aavik OR. Acrodermatitis enteropathica: review of the literature and report of a case successfully treated with diodoquin. JAMA. 1953;152(6):509–12.
Arbiser JL, et al. Clioquinol-zinc chelate: a candidate causative agent of subacute myelo-optic neuropathy. Mol Med. 1998;4(10):665.
Bareggi SR, Cornelli U. Clioquinol: review of its mechanisms of action and clinical uses in neurodegenerative disorders. CNS Neurosci Ther. 2012;18(1):41–6.
Moynahan EJ. Letter: acrodermatitis enteropathica: a lethal inherited human zinc-deficiency disorder. Lancet. 1974;2(7877):399–400.
Moynahan E. Acrodermatitis enteropathica in two siblings treated with zinc sulphate supplements alone. Proc R Soc Med. 1975;68(5):276.
Puri N. A study of efficacy of oral zinc therapy for acrodermatitis enteropathica. Nasza Dermatolologia Online. 2013;4:162–6.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Beigi, P.K.M., Maverakis, E. (2015). Disease Course and Treatment. In: Acrodermatitis Enteropathica. Springer, Cham. https://doi.org/10.1007/978-3-319-17819-6_6
Download citation
DOI: https://doi.org/10.1007/978-3-319-17819-6_6
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-17818-9
Online ISBN: 978-3-319-17819-6
eBook Packages: MedicineMedicine (R0)